AI Multi-Horizon Analysis
1m shows mild bullish impulse with RSI above 60 and price above short EMAs near upper Bollinger Band, but inconsistent session range and pre-market data limit conviction.
1H and daily charts display negative MACD, sub-40 RSI on 1H and deeply oversold daily RSI 17.6; price below major EMAs and SMAs. Recent insider sales at 640-728 add pressure despite minor 15m MACD improvement.
Revenue accelerated modestly Q3 vs Q2 (+6.3%) but operating margin collapsed from 40.62% to 20.10% and net margin from 47.54% to 15.26% over three quarters; cash down 68.7% from year-end, current ratio fell from 2.60 to 1.90, LT debt rose, FCF positive but decelerating. Weekly structure mixed but daily/monthly momentum weak; heavy insider selling continues.
META shows decelerating profitability and margins despite sequential revenue growth, heavy insider selling, sharply negative daily momentum, and inconsistent pre-market price data. Short-term relief possible from oversold levels but longer-term trend remains weak.
Detailed AI Fundamental Analysis
Business Snapshot
- Meta Platforms, Inc. Class A common stock (NASDAQ: META) is a US-listed common equity, quoted in USD. The payload identifies the company and its SEC linkage but provides no business-segment detail, guidance, valuation multiples, or analyst targets.
- Current price is $614.75 in pre-market trading. The supplied chart indicators show approximately $615; the session range is $609.00–$748.80. The unusually wide range and differences among the quoted current prices and timeframe closes are reasons to treat exact levels as approximate.
Financial Trends
- Revenue: Quarterly revenue increased from $56.311B in 2026-03-31 to $60.801B in 2026-06-30 (+$4.490B, +8.0%) and $64.601B in 2026-09-30 (+$3.800B, +6.3%). Growth continued, but the sequential dollar increase moderated. The 2025-12-31 figure of $200.966B is a full-year figure, not a comparable quarter, so a valid Q4-to-Q3 sequential comparison cannot be made from this table.
- Margins and earnings: Operating margin fell from 40.62% in 2026-03-31 to 30.88% in 2026-06-30 and 20.10% in 2026-09-30; latest versus the earliest reported quarter is −20.52 percentage points. Net margin moved from 47.54% to 26.07% to 15.26% (−32.28 points over that span). Operating income declined from $22.872B to $18.775B to $12.988B, and net income from $26.773B to $15.848B to $9.860B. These figures show a pronounced deterioration alongside revenue growth. The 2025-12-31 income statement is presented as a full-year figure, so it is not comparable to the quarterly results.
- Free cash flow (FCF): Reported FCF was $13.229B in 2026-03-31, $14.975B in 2026-06-30 (+$1.746B, +13.2%), and $13.818B in 2026-09-30 (−$1.157B, −7.7%). The latest level remains $0.589B, or 4.5%, above the earliest of those three quarterly values. The 2025-12-31 figure of $46.109B is not directly comparable because it is a full-year amount.
- Balance sheet: From 2025-12-31 to 2026-09-30, total assets rose $112.815B (+$112.815B, +30.8%) to $478.836B, while liabilities rose $57.672B (+38.8%) to $206.450B and equity rose $55.143B (+25.4%) to $272.386B. Long-term debt increased from $58.744B to $80.922B; it rose notably between March and June, then eased $2.742B in the latest quarter. Cash declined each reported period, from $35.873B at year-end to $11.222B latest (−$24.651B, −68.7%). The current ratio likewise fell from 2.60 to 1.90; working capital fell from $66.886B to $56.889B.
Financial Health
- The latest balance sheet still shows positive working capital of $56.889B, shareholders’ equity of $272.386B, and a current ratio of 1.90. Those figures indicate a sizable equity base and current assets above current liabilities, but the downward cash and current-ratio trends reduce the cushion compared with year-end.
- The main financial concern in the supplied trend is profitability: revenue rose sequentially, while operating income, net income, and both reported margins fell across the latest three comparable quarters. The latest quarter’s 20.10% operating margin is materially below 40.62% in March.
- FCF remains positive at $13.818B in the latest quarter, but is down from June. The cash-flow table also reports capital expenditures of $83.055B latest versus $49.113B in June and $18.997B in March, while cash and equivalents continued to fall. Because the table labels these as quarterly figures but the magnitudes and reported FCF do not reconcile straightforwardly, interpret the cash-flow line items cautiously rather than assuming a clean quarter-over-quarter cash-generation bridge.
Insider Activity
- Insider sentiment is Neutral (-10) for 2026-08-04 to 2026-11-02, with reported sales of $84.33M across 52 transactions and buys of $0 across 1 transaction. The reported net is −$84.33M.
- The listed Form 4 activity is predominantly sales by Peggy Alford and Javier Olivan. Olivan’s repeated transactions were reported at $728.08–$728.10 on October 5, $728.10 on October 12, $707.20 on October 19, and $640 on October 26; Alford’s listed sale was also at $640 on October 26.
- This is a negative insider-flow signal, but the data do not establish whether the sales were discretionary or part of a prearranged plan. Insider selling alone does not determine the stock’s direction.
Multi-Timeframe Technical Context
- Ultra-short (minutes): The 1-minute close is $615.06, with RSI(14) 62.34 and MACD above its signal (0.431 vs. 0.354). Price is above EMA 12/26/50 and the SMA 20/50/200, indicating a short-lived positive impulse. Volume is above its 20-bar average (5,851 vs. 2,789), while price is near the upper Bollinger Band ($615.22), so the immediate bounce may meet short-term resistance.
- Short (hours to days): The 15-minute RSI(14) is 50.31; MACD remains negative but is above its signal (−0.310 vs. −0.509), consistent with improving momentum rather than a confirmed trend reversal. Price is above EMA 12/26 but below EMA 50 and SMA 200 ($617.93). On the 1-hour chart, RSI(14) is 32.42, MACD is negative and below its signal, and price is below EMA 26/50 and SMA 20/50/200. The 1-hour downtrend remains dominant, though price is near the lower Bollinger Band at $607.92.
- Long (weeks to months): The daily chart is deeply weak: RSI(14) 17.63, MACD −20.53 versus signal −6.87, and price is well below EMA 12/26/50 and SMA 20/50. The weekly chart is more mixed: RSI(14) 52.18, MACD above signal, and price near/under the SMA 20/50 area ($629–$631) but below EMA 12/26/50 ($637–$655). Monthly RSI is 41.39 and MACD is below its signal, despite price remaining above the monthly EMA 26/50 and SMA 50. Overall, shorter-term structure is bearish; weekly and monthly readings offer some support but do not yet confirm a durable recovery.
- Volatility and data caveat: Daily ATR is $25.05, weekly ATR $57.21, and monthly ATR $116.50, indicating substantial price variability. The session high of $748.80 is far from the supplied current price and chart closes near $615, so treat quoted intraday extremes and nearby technical levels cautiously.
Bull / Bear Cases
- Short-term bull case: The 1-minute momentum and 15-minute MACD improvement, together with daily RSI at 17.63, allow for a relief bounce from the $609–$608 area. A sustained move back above the 1-hour short-term averages and the 15-minute SMA 200 near $618 would improve the near-term setup.
- Short-term bear case: The 1-hour chart remains below key moving averages with negative MACD, and the daily trend is sharply weak. Failure to hold the $609–$608 area could expose lower support, while a rebound that stalls around $618–$624 would leave the downtrend intact.
- Long-term bull case: Quarterly revenue advanced from $56.311B to $64.601B across the three comparable quarters, and reported FCF remained positive. Weekly RSI and MACD are not as weak as the daily readings, which leaves room for stabilization if profitability and cash trends stop deteriorating.
- Long-term bear case: Operating and net margins compressed sharply as revenue grew; cash fell 68.7% from year-end, long-term debt is higher than at year-end, and the current ratio declined from 2.60 to 1.90. The daily and monthly momentum signals remain weak. Continued margin pressure or further deterioration in cash and liquidity would weigh on the fundamental recovery case.
Key Levels & Triggers
- Immediate support: $609.00–$607.92, combining the stated session low and 1-hour lower Bollinger Band. A decisive break below this zone would weaken the near-term stabilization case.
- Next chart reference: Daily lower Bollinger Band near $589.26; it is a technical reference, not a guaranteed floor.
- Initial resistance: $615–$618, around the current price, 1-hour SMA 20 ($615.81), and 15-minute SMA 200 ($617.93).
- Higher resistance: $623.70 (1-hour upper Bollinger Band), then the weekly SMA 20/50 area around $629–$631. Reclaiming and holding these levels would be more meaningful than a brief intraday bounce.
- Fundamental triggers to monitor: Whether revenue growth continues while operating and net margins stabilize; whether quarterly FCF holds near recent levels; and whether cash, long-term debt, and the current ratio stop moving in the unfavorable direction.
- Trading read: NO_TRADE pending confirmation: ultra-short momentum is improving, but the 1-hour and daily trends remain bearish and the reported price/session data are unusually inconsistent.